Skip to main content
Premium Trial:

Request an Annual Quote

Dxcover: David Eustace

David Eustace has been appointed as operations director of cancer liquid biopsy startup Dxcover (previously ClinSpec Dx). He joins the Strathclyde University spinout from Bruker Daltonics, where he was operations director in Germany and Scotland. Previously, he worked for Renishaw Diagnostics. Eustace holds a PhD from the University of Glasgow.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.